Income Statement Cosmos Health Inc.

Stocks

COSM

US2214133058

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 02:57:56 2026-07-14 pm EDT			5-day change	1st Jan Change
0.3010 ^USD	-2.40%		+19.79%	-38.25%

Jul. 02	Cosmos Health Expands Share Buyback to 3.4 Million Shares	MT
Jun. 30	Cosmos Health Inc. announces an Equity Buyback for $5 million worth of its shares.	CI

9131ecc156f6be72.rxGCGqQchmgCx5VMby9P5X8tZzZ5MdDSzAQp1qm8joI.yn36TZBE9V5onv0YN0AGn0huHn9LYIGxm2kfn-_66dDCX9pXykarOFKp2A

Published financial data: COSMOS HEALTH INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	56.24M	50.35M	53.38M	54.43M	65.27M
Total Revenues	56.24M	50.35M	53.38M	54.43M	65.27M
Cost of Goods Sold, Total	47.91M	44.39M	49.03M	50.12M	57.38M
Gross Profit	8.33M	5.96M	4.35M	4.31M	7.9M
Selling General & Admin Expenses, Total	12.41M	13.24M	25.57M	17.78M	22.55M
R&D Expenses	-	-	-	533K	519K
Depreciation & Amortization - (IS)	450K	189K	614K	1.25M	1.37M
Other Operating Expenses, Total	12.86M	13.43M	26.18M	19.56M	24.44M
Operating Income	-4.53M	-7.47M	-21.83M	-15.25M	-16.54M
Interest Expense, Total	-3.58M	-3.97M	-866K	-1.01M	-2.62M
Interest And Investment Income	46.32K	236K	663K	406K	396K
Net Interest Expenses	-3.53M	-3.73M	-204K	-606K	-2.23M
Currency Exchange Gains (Loss)	-494K	-413K	199K	-122K	340K
Other Non Operating Income (Expenses)	-72.82K	-2.44M	-62.48K	86.74K	703K
EBT, Excl. Unusual Items	-8.63M	-14.06M	-21.9M	-15.89M	-17.72M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	2.54K	1.68K	4.58K	2.47K	21.37K
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-292K	-163K
Other Unusual Items	784K	1M	3.35M	-	-1.28M
EBT, Incl. Unusual Items	-7.85M	-13.06M	-18.54M	-16.18M	-19.14M
Income Tax Expense	114K	775K	-	-	-
Earnings From Continuing Operations	-7.96M	-13.83M	-18.54M	-16.18M	-19.14M
Net Income to Company	-7.96M	-13.83M	-18.54M	-16.18M	-19.14M
Net Income - (IS)	-7.96M	-13.83M	-18.54M	-16.18M	-19.14M
Preferred Dividend and Other Adjustments	7.63M	50.11M	7.24M	6.2M	-
Net Income to Common Incl Extra Items	-15.59M	-63.95M	-25.78M	-22.38M	-19.14M
Net Income to Common Excl. Extra Items	-15.59M	-63.95M	-25.78M	-22.38M	-19.14M
Per Share Items
Net EPS - Basic	-23.74	-33.16	-2.15	-1.17	-0.63
Basic EPS - Continuing Operations	-23.74	-33.16	-2.15	-1.17	-0.63
Basic Weighted Average Shares Outstanding	657K	1.93M	11.97M	19.15M	30.29M
Net EPS - Diluted	-23.75	-33.16	-2.15	-1.17	-0.63
Diluted EPS - Continuing Operations	-23.75	-33.16	-2.15	-1.17	-0.63
Diluted Weighted Average Shares Outstanding	657K	1.93M	11.97M	19.15M	30.29M
Normalized Basic EPS	-8.21	-4.56	-1.14	-0.52	-0.37
Normalized Diluted EPS	-8.21	-4.56	-1.14	-0.52	-0.37
Supplemental Items
EBITDA	-4.18M	-7.37M	-21.24M	-14.03M	-15.18M
EBITA	-4.5M	-7.44M	-21.59M	-14.46M	-15.62M
EBIT	-4.53M	-7.47M	-21.83M	-15.25M	-16.54M
EBITDAR	-3.92M	-7.16M	-20.88M	-13.74M	-14.92M
Effective Tax Rate - (Ratio)	-1.45	-5.94	-	-	-
Current Foreign Taxes	802K	-75.72K	-	-	-
Total Current Taxes	802K	-75.72K	-	-	-
Deferred Foreign Taxes	-688K	851K	-	-	-
Total Deferred Taxes	-688K	851K	-	-	-
Normalized Net Income	-5.4M	-8.79M	-13.69M	-9.93M	-11.08M
Interest on Long-Term Debt	11.58K	16.47K	2.9K	2.06K	528
Supplemental Operating Expense Items
Selling and Marketing Expenses	733K	630K	1.2M	355K	150K
General and Administrative Expenses	8.95M	9.97M	19.28M	11.44M	15.36M
Research And Development Expense From Footnotes	-	-	-	533K	519K
Net Rental Expense, Total	261K	210K	365K	297K	264K
Imputed Operating Lease Interest Expense	240K	316K	195K	198K	348K
Imputed Operating Lease Depreciation	20.85K	-106K	170K	98.56K	-84.4K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	994K	1.05M
Stock-Based Comp., Other (Total)	5.9M	200K	675K	696K	1.26M
Total Stock-Based Compensation	5.9M	200K	675K	1.69M	2.31M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	286K	20.75M	3.83M	315K	716K
Short Term Investments	6.7K	14.88K	20.08K	21.15K	46.16K
Total Cash And Short Term Investments	293K	20.76M	3.85M	336K	762K
Accounts Receivable, Total	26.86M	22.76M	19.76M	13.48M	19.63M
Other Receivables	2.9M	3.26M	1.54M	2.32M	2.9M
Notes Receivable	378K	377K	412K	614K	488K
Total Receivables	30.14M	26.4M	21.71M	16.41M	23.01M
Inventory	6.41M	6.77M	4.79M	4.36M	5.78M
Prepaid Expenses	2.99M	1.97M	6.25M	4.35M	5.9M
Restricted Cash	-	-	-	-	2.74M
Other Current Assets, Total	1.05M	143K	-	-1	194K
Total Current Assets	40.88M	56.04M	36.61M	25.46M	38.39M
Gross Property Plant And Equipment	2.82M	3.81M	12.66M	11.67M	13.3M
Accumulated Depreciation	-942K	-878K	-1.05M	-1.28M	-2.12M
Net Property Plant And Equipment	1.88M	2.93M	11.62M	10.4M	11.18M
Long-term Investments	170K	160K	166K	-	-
Goodwill	49.7K	49.7K	49.7K	49.7K	49.7K
Other Intangibles, Total	443K	657K	7.63M	7.71M	7.52M
Loans Receivable Long-Term	4.41M	7.64M	7.05M	5.77M	3.15M
Deferred Tax Assets Long-Term	851K	-	-	-	-
Other Long-Term Assets, Total	745K	553K	2.89M	4.92M	5.19M
Total Assets	49.43M	68.04M	66.01M	54.31M	65.48M
Liabilities
Accounts Payable, Total	12.33M	11.72M	12.06M	12.43M	16.63M
Accrued Expenses, Total	1.42M	676K	246K	222K	786K
Short-term Borrowings	7.84M	5.88M	6.65M	7M	9.19M
Current Portion of Long-Term Debt	5.5M	2.16M	1.57M	2.55M	4.33M
Current Portion of Leases	212K	264K	313K	208K	226K
Current Income Taxes Payable	1.32M	127K	-	-	-
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	1.3M	917K	3.47M	3.35M	7.11M
Total Current Liabilities	29.93M	21.75M	24.32M	25.76M	38.27M
Long-Term Debt	14.28M	4.41M	3.04M	1.56M	5.85M
Long-Term Leases	844K	860K	850K	502K	373K
Other Non Current Liabilities	-	1.36M	1.76M	1.96M	2.56M
Total Liabilities	45.05M	28.38M	29.97M	29.78M	47.05M
Preferred Stock Convertible	-	372K	-	-	-
Total Preferred Equity	-	372K	-	-	-
Common Stock, Total	17.54K	10.61K	15.98K	23.69K	41.15K
Additional Paid In Capital	39.68M	112M	129M	142M	152M
Retained Earnings	-34.35M	-66.23M	-91.64M	-114M	-133M
Treasury Stock	-817K	-817K	-917K	-917K	-917K
Comprehensive Income and Other	-152K	-5.88M	-420K	-2.13M	332K
Total Common Equity	4.38M	39.28M	36.04M	24.53M	18.42M
Total Equity	4.38M	39.66M	36.04M	24.53M	18.42M
Total Liabilities And Equity	49.43M	68.04M	66.01M	54.31M	65.48M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	702K	10.61M	15.9M	27.2M	50.74M
ECS Total Common Shares Outstanding	686K	10.59M	15.9M	23.6M	41.07M
Book Value / Share	6.38	3.71	2.27	1.04	0.45
Tangible Book Value	3.89M	38.58M	28.36M	16.78M	10.85M
Tangible Book Value Per Share	5.66	3.64	1.78	0.71	0.26
Total Debt	28.68M	13.58M	12.42M	11.82M	19.97M
Net Debt	28.38M	-7.18M	8.57M	11.48M	19.21M
Debt Equivalent Oper. Leases	2.09M	1.68M	2.92M	2.38M	2.11M
Equity Method Investments, Total	170K	160K	166K	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	-	-	-	226K	236K
Inventories - Finished Goods, Total	-	-	-	4.16M	5.78M
Inventories - Others	-	-	-	298K	142K
Land - (BS)	-	-	3.55M	3.32M	3.77M
Buildings, Total	-	-	4.79M	4.53M	5.3M
Machinery, Total	2.3M	2.19M	3.16M	3.11M	3.62M
Full Time Employees	95	102	123	149	163
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.7M	7.31M	19.69M	22.8M	30.65M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-7.96M	-13.83M	-18.54M	-16.18M	-19.14M
Depreciation & Amortization - CF	417K	156K	375K	455K	444K
Amortization of Goodwill and Intangible Assets - (CF)	33.08K	33.08K	240K	794K	925K
Depreciation & Amortization, Total	450K	189K	614K	1.25M	1.37M
Amortization of Deferred Charges, Total - (CF)	757K	1.62M	-	-	723K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	209K	-1.68K	-4.58K	-2.47K	-21.37K
Asset Writedown & Restructuring Costs	-	-	-	454K	163K
Stock-Based Compensation (CF)	5.9M	200K	675K	1.69M	2.31M
Provision and Write-off of Bad Debts	1.09M	5.62M	11.85M	4.64M	5.88M
Other Operating Activities, Total	-1.24M	23.16K	-2.33M	277K	1.05M
Change In Accounts Receivable	-5.79M	-3.24M	-4.03M	1.23M	-6.11M
Change In Inventories	-89.58K	-485K	-891K	146K	-830K
Change In Accounts Payable	3.82M	1.73M	717K	1.05M	4.47M
Change in Unearned Revenues	-	-	-	-	-
Change In Income Taxes	622K	-1.11M	-129K	-	-
Change in Other Net Operating Assets	-4.86M	-5.59M	-3.57M	-2.26M	1.69M
Cash from Operations	-7.1M	-14.87M	-15.64M	-7.72M	-8.45M
Capital Expenditure	-581K	-74.21K	-2.98M	-418K	-55.68K
Sale of Property, Plant, and Equipment	-	12.74K	-	-	-
Cash Acquisitions	-	-	-5.23M	-	-
Sale (Purchase) of Intangible assets	-309K	-309K	-6.19M	-849K	-97.14K
Investment in Marketable and Equity Securities, Total	-	-2.63K	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	63.7K	351K	806K	469K	138K
Other Investing Activities, Total	-	-	-168K	-	-2M
Cash from Investing	-827K	-21.5K	-13.76M	-798K	-2.01M
Short Term Debt Issued, Total	8.02M	25.98M	20.19M	25.96M	27.91M
Long-Term Debt Issued, Total	25.03M	552K	1.06M	866K	11.16M
Total Debt Issued	33.05M	26.53M	21.25M	26.83M	39.06M
Short Term Debt Repaid, Total	-1.05M	-27.81M	-19.63M	-25.15M	-26.7M
Long-Term Debt Repaid, Total	-24.61M	-12.58M	-1.64M	-1.13M	-1.89M
Total Debt Repaid	-25.66M	-40.39M	-21.27M	-26.28M	-28.6M
Issuance of Common Stock	250K	46.1M	13.53M	4.89M	5.42M
Repurchase of Common Stock	-377K	-	-100K	-	-
Issuance of Preferred Stock	-	6M	-	-	-
Other Financing Activities, Total	-	-3.19M	-718K	-392K	-1.83M
Cash from Financing	7.27M	35.05M	12.69M	5.05M	14.06M
Foreign Exchange Rate Adjustments	314K	307K	-214K	-49.47K	-449K
Net Change in Cash	-342K	20.46M	-16.92M	-3.52M	3.14M
Supplemental Items
Cash Interest Paid	2.06M	588K	407K	705K	947K
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	2.56M	-4.2M	-16.88M	-650K	-11.7M
Unlevered Free Cash Flow	4.04M	-3.34M	-16.33M	-16.84K	-10.78M
Change In Net Working Capital	-1.41M	-1.33M	-5.19M	-7.84M	3.97M
Net Debt Issued / Repaid	7.39M	-13.86M	-21.41K	548K	10.47M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-6.08	-7.95	-20.36	-15.85	-17.26
Return on Total Capital	-9.07	-10.83	-26.83	-22.48	-27.66
Return On Equity %	-7.29K	-62.81	-48.99	-53.43	-89.13
Return on Common Equity	-14.28K	-292.9	-68.46	-73.88	-89.13
Margin Analysis
Gross Profit Margin %	14.81	11.83	8.15	7.92	12.1
SG&A Margin	22.07	26.3	47.9	32.67	34.54
EBITDA Margin %	-7.43	-14.64	-39.79	-25.78	-23.26
EBITA Margin %	-8	-14.78	-40.45	-26.57	-23.92
EBIT Margin %	-8.06	-14.84	-40.9	-28.02	-25.34
Income From Continuing Operations Margin %	-14.16	-27.47	-34.74	-29.73	-29.33
Net Income Margin %	-14.16	-27.47	-34.74	-29.73	-29.33
Net Avail. For Common Margin %	-27.73	-127.01	-48.31	-41.12	-29.33
Normalized Net Income Margin	-9.6	-17.46	-25.64	-18.25	-16.97
Levered Free Cash Flow Margin	4.55	-8.34	-31.62	-1.19	-17.92
Unlevered Free Cash Flow Margin	7.18	-6.63	-30.6	-0.03	-16.52
Asset Turnover
Asset Turnover	1.21	0.86	0.8	0.9	1.09
Fixed Assets Turnover	30.92	17.17	7.34	4.97	6.05
Receivables Turnover (Average Receivables)	2.24	2.04	2.46	3.27	3.94
Inventory Turnover (Average Inventory)	7.27	6.73	11.9	10.96	11.32
Short Term Liquidity
Current Ratio	1.37	2.58	1.51	0.99	1
Quick Ratio	1	2.15	1.03	0.63	0.61
Operating Cash Flow to Current Liabilities	-0.24	-0.68	-0.64	-0.3	-0.22
Days Sales Outstanding (Average Receivables)	163.22	178.54	148.56	111.76	92.57
Days Outstanding Inventory (Average Inventory)	50.17	54.2	30.68	33.39	32.23
Average Days Payable Outstanding	92.64	98.07	80.89	90.5	90.18
Cash Conversion Cycle (Average Days)	120.76	134.66	98.35	54.64	34.62
Long Term Solvency
Total Debt/Equity	654.83	34.24	34.47	48.18	108.39
Total Debt / Total Capital	86.75	25.51	25.63	32.52	52.01
LT Debt/Equity	345.28	13.3	10.78	8.41	33.79
Long-Term Debt / Total Capital	45.74	9.91	8.02	5.67	16.21
Total Liabilities / Total Assets	91.14	41.71	45.4	54.83	71.86
EBIT / Interest Expense	-1.27	-1.88	-25.2	-15.07	-6.31
EBITDA / Interest Expense	-1.09	-1.81	-24.09	-13.57	-5.69
(EBITDA - Capex) / Interest Expense	-1.26	-1.82	-27.53	-13.98	-5.71
Total Debt / EBITDA	-7.32	-1.9	-0.6	-0.86	-1.34
Net Debt / EBITDA	-7.24	1	-0.41	-0.84	-1.29
Total Debt / (EBITDA - Capex)	-6.37	-1.88	-0.52	-0.84	-1.33
Net Debt / (EBITDA - Capex)	-6.31	0.99	-0.36	-0.81	-1.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.5	-10.48	6.02	1.97	19.93
Gross Profit, 1 Yr. Growth %	3.35	-28.49	-26.98	-0.88	83.14
EBITDA, 1 Yr. Growth %	-239.91	76.29	188.17	-33.93	8.17
EBITA, 1 Yr. Growth %	-263.8	65.34	190.17	-33.03	8
EBIT, 1 Yr. Growth %	-267.02	64.87	192.09	-30.13	8.44
Earnings From Cont. Operations, 1 Yr. Growth %	-1.07K	73.71	34.07	-12.73	18.3
Net Income, 1 Yr. Growth %	-1.07K	73.71	34.07	-12.73	18.3
Normalized Net Income, 1 Yr. Growth %	-3.07K	62.85	55.74	-27.42	11.52
Diluted EPS Before Extra, 1 Yr. Growth %	-1.68K	39.7	-93.5	-45.69	-45.98
Accounts Receivable, 1 Yr. Growth %	14.58	-14.08	-16.6	-31.79	45.63
Inventory, 1 Yr. Growth %	-5.19	5.64	38.74	-9.06	32.67
Net Property, Plant and Equip., 1 Yr. Growth %	7.03	-0.13	296.46	-9.51	7.5
Total Assets, 1 Yr. Growth %	12.74	37.65	-2.97	-17.73	20.56
Tangible Book Value, 1 Yr. Growth %	-188.5	890.76	-26.49	-40.58	-35.3
Common Equity, 1 Yr. Growth %	-205.25	797.01	-8.25	-31.93	-24.9
Cash From Operations, 1 Yr. Growth %	-38.29	109.53	5.15	-50.65	9.47
Capital Expenditures, 1 Yr. Growth %	393.78	-87.24	3.91K	-85.96	-86.68
Levered Free Cash Flow, 1 Yr. Growth %	-118.46	-216.37	273.45	-96.15	1.7K
Unlevered Free Cash Flow, 1 Yr. Growth %	-133.27	-165.62	346.23	-99.9	63.93K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	19.06	-4.67	-2.58	3.97	10.58
Gross Profit, 2 Yr. CAGR %	50.82	-14.03	-27.74	-14.93	34.73
EBITDA, 2 Yr. CAGR %	1.29K	57.05	125.39	37.98	-15.46
EBITA, 2 Yr. CAGR %	349.51	64.57	119.04	39.4	-14.96
EBIT, 2 Yr. CAGR %	320.97	65.94	119.45	42.86	-12.96
Earnings From Cont. Operations, 2 Yr. CAGR %	55.35	310.49	52.61	8.17	1.61
Net Income, 2 Yr. CAGR %	55.35	310.49	52.61	8.17	1.61
Normalized Net Income, 2 Yr. CAGR %	113.4	595.44	59.26	6.32	-10.03
Diluted EPS Before Extra, 2 Yr. CAGR %	94.94	370.2	-69.88	-81.22	-45.83
Accounts Receivable, 2 Yr. CAGR %	91.17	-1.46	-13.64	-24.57	-0.33
Inventory, 2 Yr. CAGR %	4.03	0.08	-13.57	12.33	9.84
Net Property, Plant and Equip., 2 Yr. CAGR %	4.12	29.13	98.99	88.4	-1.37
Total Assets, 2 Yr. CAGR %	43.87	24.57	15.57	-10.66	-0.41
Tangible Book Value, 2 Yr. CAGR %	-23.98	196.39	169.88	-34.05	-38
Common Equity, 2 Yr. CAGR %	-17.67	207.26	186.88	-20.97	-28.5
Cash From Operations, 2 Yr. CAGR %	21.74	13.71	48.43	-27.96	-26.5
Capital Expenditures, 2 Yr. CAGR %	-7.04	-20.61	126.33	137.36	-86.33
Levered Free Cash Flow, 2 Yr. CAGR %	-29.87	-44.95	116.32	-62.09	-16.74
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.59	-47.55	79.18	-93.22	-18.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.89	8.26	-1.24	-1.09	9.04
Gross Profit, 3 Yr. CAGR %	51.23	17.6	-18.59	-19.71	9.85
EBITDA, 3 Yr. CAGR %	52.26	597.48	92.27	49.73	27.23
EBITA, 3 Yr. CAGR %	54.55	222.07	98.82	47.56	28.03
EBIT, 3 Yr. CAGR %	54.53	208	100.36	49.84	30.32
Earnings From Cont. Operations, 3 Yr. CAGR %	-4.22	61.24	182.69	26.67	11.45
Net Income, 3 Yr. CAGR %	-4.22	61.24	182.69	26.67	11.45
Normalized Net Income, 3 Yr. CAGR %	1.2	95.01	322.32	22.56	8.02
Diluted EPS Before Extra, 3 Yr. CAGR %	11.74	74.42	12.82	-63.34	-73.29
Accounts Receivable, 3 Yr. CAGR %	78.11	45.77	-5.54	-20.17	-6.08
Inventory, 3 Yr. CAGR %	-6.34	4.56	-10.86	-12.09	18.73
Net Property, Plant and Equip., 3 Yr. CAGR %	9.67	19.09	87.68	52.48	56.26
Total Assets, 3 Yr. CAGR %	33.67	41.77	14.62	3.19	-1.27
Tangible Book Value, 3 Yr. CAGR %	2.45	79.02	86.22	62.72	-34.47
Common Equity, 3 Yr. CAGR %	9.7	82.52	105.37	77.6	-22.3
Cash From Operations, 3 Yr. CAGR %	65.87	45.89	10.78	2.83	-17.18
Capital Expenditures, 3 Yr. CAGR %	4.92	-52.04	193.54	-10.41	-9.13
Levered Free Cash Flow, 3 Yr. CAGR %	10.99	-6.88	6.82	-43.53	37.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.99	-9.03	10.42	-85.1	43.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	52.78	10.9	7.56	6.53	3.33
Gross Profit, 5 Yr. CAGR %	69.18	24.95	12.55	3.32	-0.41
EBITDA, 5 Yr. CAGR %	84.98	20.54	78.13	264.8	38.41
EBITA, 5 Yr. CAGR %	85.93	20.62	77.68	130.4	41.56
EBIT, 5 Yr. CAGR %	86.21	20.66	77.81	126.51	43.54
Earnings From Cont. Operations, 5 Yr. CAGR %	67.66	17.37	15.4	37.45	87.74
Net Income, 5 Yr. CAGR %	67.66	17.37	15.4	37.45	87.74
Normalized Net Income, 5 Yr. CAGR %	70.44	26.99	21.32	52.99	127.52
Diluted EPS Before Extra, 5 Yr. CAGR %	80.2	22.04	-33.86	-28.47	-15.87
Accounts Receivable, 5 Yr. CAGR %	109.73	78.51	32.97	12.9	-3.49
Inventory, 5 Yr. CAGR %	69.06	16.96	-9.3	-5.97	-3.09
Net Property, Plant and Equip., 5 Yr. CAGR %	104.4	91.23	52.13	43.07	44.78
Total Assets, 5 Yr. CAGR %	73.78	44.83	26.11	17.86	8.35
Tangible Book Value, 5 Yr. CAGR %	17.26	65.9	50.99	20.06	19.84
Common Equity, 5 Yr. CAGR %	20.1	66.96	61.14	30.58	34.66
Cash From Operations, 5 Yr. CAGR %	27.26	11.16	58.66	10.01	-5.99
Capital Expenditures, 5 Yr. CAGR %	114.46	6.04	42.7	-9.08	-13.91
Levered Free Cash Flow, 5 Yr. CAGR %	10.44	-8.59	55.27	-34.03	-3.32
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.84	-11.27	37.72	-67.2	-2.33